Trastuzumab deruxtecan

Trastuzumab deruxtecan

Cat Number
API1826843815
CAS Number
1826843-81-5

For research use only. We do not supply to patients.

For pharmaceutical-grade products or other inquiries, please contact our experts.

CAS Number
1826843-81-5
Description
Trastuzumab deruxtecan (T-DXd) is an antibody-active molecule conjugate (ADC) with anticancer and antitumor activity, which is composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) coupled to a topoisomerase I inhibitor (DXd). Trastuzumab deruxtecan has an improved effect on the treatment of HER2-positive breast cancer and gastric cancer.
Molecular Weight
145 kDa (average)
Purity
98.49% (SEC-HPLC)
You Might Also Like
Hetacillin
Hetacillin

Cat NO.: API0232088
CAS NO.: 3511-16-8

View Details
Flubendazole-d3 (methyl-d3)
Flubendazole-d3 (methyl-d3)

Cat NO.: API1173021083
CAS NO.: 1173021-08-3

View Details
Rucaparib tartrate
Rucaparib tartrate

Cat NO.: API773059226
CAS NO.: 773059-22-6

View Details
Meprednisone
Meprednisone

Cat NO.: API1247423
CAS NO.: 1247-42-3

View Details
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Contact Us
USA

Tel:
Email:
Address:

 
Denmark

Tel:
Email:
Address:

WhatsAPP
WhatsAPP (Sales #1)
WhatsAPP
WhatsAPP (Sales #2)
WhatsAPP
WhatsAPP (Sales #3)

All our products are chemicals for research purposes only. We do not supply for human or veterinary applications.

Privacy Policy | Cookie Policy Copyright © Protheragen. All Rights Reserved.


WhatsAPP
Top